The Burden Of Weight Loss Drugs: Is It Worth The Risk? | Vantage With Palki Sharma | N18G

The Burden Of Weight Loss Drugs: Is It Worth The Risk? | Vantage With Palki Sharma | N18G

Weight loss drugs like Ozempic, Wegovy, and Mounjaro are being hailed as revolutionary, reshaping bodies, lives, and a booming $15 billion industry. But behind the hype lies a growing concern: shortages, black markets, and serious side effects ranging from stomach paralysis to suicidal thoughts. As demand soars and influencers drive the trend, experts warn we may be living through a massive human experiment.

—
Weight Loss Drugs | Ozempic | Wegovy | Mounjaro | Diabetes | GLP-1 Drugs | Firstpost | World News | News Live | Vantage | Palki Sharma | News

#weightloss #ozempic #wegovry #mounjaro #diabetes #medicine #glp1 #drugs #firstpost #vantageonfirstpost #palkisharma #worldnews

Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.

The show is anchored by Palki Sharma, Managing Editor, Firstpost.

By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.

Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.

Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
https://www.youtube.com/@Firstpost

Follow Firstpost on Instagram:
https://www.instagram.com/firstpost/

Follow Firstpost on Facebook:
https://www.facebook.com/firstpostin/

Follow Firstpost on Twitter:
Tweets by firstpost

Follow Firstpost on WhatsApp:
https://www.whatsapp.com/channel/0029Va6zOIrEQIamseyg762V